Literature DB >> 1897561

A dose-related curve of wound tensile strength following ultraviolet irradiation in the hairless guinea pig.

S K Brantley1, S F Davidson, S K Das.   

Abstract

A dose-related curve of wound tensile strength was derived following exposure to three doses of predominantly UVA (Ultraviolet A) radiation (98.3% between 315 nm and 400 nm, 1.7% less than 315 nm). Forty female hairless guinea pigs were divided into four equal groups: Group 1 (controls); Group 2 (40 J[Joules]/cm2/day); Group 3 (80 J/cm2); and Group 4 (160 J/cm2). Preoperatively, the experimental groups were irradiated on alternate days for 16 weeks. Serial dorsal punch biopsies (4 mm) were taken prior to the initial exposure and subsequently at 2, 4, 8, 12, and 16 weeks and examined histologically and microscopically. Then, standard 6 cm midline dorsal surgical wounds were made and allowed to heal for 21 days. Wounds were excised and wound tensile strength was assessed. Significant decreases (p less than .05) were noted in wound tensile strength of Groups 2, 3, and 4 compared to the controls, with the decrease being directly related to the dose received. Dermal changes were noted in all irradiated groups as early as four weeks after initial UVA/B exposure. Electron microscopy revealed elastosis and disruption of collagen fibers. Prolonged exposure to radiation, predominantly in the UVA range, appears to impede wound healing in a dose-related fashion and elicits elastosis and collagen disruption.

Entities:  

Mesh:

Year:  1991        PMID: 1897561     DOI: 10.1097/00000441-199108000-00002

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  2 in total

1.  Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology.

Authors:  W Lin; M Cormier; A Samiee; A Griffin; B Johnson; C L Teng; G E Hardee; P E Daddona
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

2.  Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization.

Authors:  James A Matriano; Michel Cormier; Juanita Johnson; Wendy A Young; Margaret Buttery; Kofi Nyam; Peter E Daddona
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.